Old Web
English
Sign In
Acemap
>
authorDetail
>
Anette L. Søndergaard
Anette L. Søndergaard
Semaglutide
once weekly
Medicine
Internal medicine
Baseline (configuration management)
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial
2021
Diabetes
Juan P. Frias
Pernille Auerbach
Harpreet S. Bajaj
Yasushi Fukushima
Ildiko Lingvay
Stanislava Macura
Anette L. Søndergaard
Tsvetalina Tankova
Nikolaos Tentolouris
John B. Buse
Show All
Source
Cite
Save
Citations (0)
Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
2021
Canadian Journal of Diabetes
Buse John
Pernille Auerbach
Harpreet S. Bajaj
Yasushi Fukushima
Ildiko Lingvay
Stanislava Macura
Anette L. Søndergaard
Tsvetalina Tankova
Nikolaos Tentolouris
Juan P. Frias
Show All
Source
Cite
Save
Citations (0)
665-P: Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs. 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
2021
Diabetes
John B. Buse
Pernille Auerbach
Harpreet S. Bajaj
Yasushi Fukushima
Ildiko Lingvay
Stanislava Macura
Anette L. Søndergaard
Tsvetalina Tankova
Nikolaos Tentolouris
Juan P. Frias
Show All
Source
Cite
Save
Citations (0)
1